K. Bee

An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.

H. Sampson, D. Fleischer, D. Campbell, 2020, Allergy and asthma proceedings.

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

A. Burks, H. Sampson, B. Vickery, 2023, The New England journal of medicine.

Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy.

H. Sampson, D. Fleischer, D. Campbell, 2020, Allergy and asthma proceedings.

Recent advances in epicutaneous immunotherapy and potential applications in food allergy

P. Hervé, V. Dioszeghy, K. Bee, 2023, Frontiers in allergy.